These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17468865)

  • 1. Cardiovascular drugs and the risk of suicide: a nested case-control study.
    Callréus T; Agerskov Andersen U; Hallas J; Andersen M
    Eur J Clin Pharmacol; 2007 Jun; 63(6):591-6. PubMed ID: 17468865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.
    Sørensen HT; Mellemkjaer L; Olsen JH
    Br J Clin Pharmacol; 2001 Sep; 52(3):313-8. PubMed ID: 11560564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis.
    Hallas J
    Epidemiology; 1996 Sep; 7(5):478-84. PubMed ID: 8862977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression.
    Dunn NR; Freemantle SN; Mann RD
    Br J Clin Pharmacol; 1999 Aug; 48(2):230-3. PubMed ID: 10417501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular drug prescriptions and risk of depression in diabetic patients.
    Rathmann W; Haastert B; Roseman JM; Giani G
    J Clin Epidemiol; 1999 Nov; 52(11):1103-9. PubMed ID: 10527005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive medications and risk of community-acquired pneumonia.
    Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
    J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential oral manifestations of cardiovascular drugs.
    Habbab KM; Moles DR; Porter SR
    Oral Dis; 2010 Nov; 16(8):769-73. PubMed ID: 20604876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk, drugs and erectile function--a systematic analysis.
    Baumhäkel M; Schlimmer N; Kratz M; Hackett G; Jackson G; Böhm M
    Int J Clin Pract; 2011 Mar; 65(3):289-98. PubMed ID: 21314866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-lowering drugs and the risk of depression and suicidal behavior.
    Yang CC; Jick SS; Jick H
    Arch Intern Med; 2003 Sep; 163(16):1926-32. PubMed ID: 12963565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.
    Meier CR; Derby LE; Jick SS; Jick H
    Arch Intern Med; 2000 Feb; 160(3):349-53. PubMed ID: 10668837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive drugs and the risk of incident rosacea.
    Spoendlin J; Voegel JJ; Jick SS; Meier CR
    Br J Dermatol; 2014 Jul; 171(1):130-6. PubMed ID: 24428524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization.
    Albani S; Fabris E; Doimo S; Barbati G; Perkan A; Merlo M; Gatti G; Di Lenarda A; Van't Hof AWJ; Maras P; Sinagra G
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):195-201. PubMed ID: 29846559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
    Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
    Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blockers and risk of cancer.
    Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
    Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
    Naderi SH; Bestwick JP; Wald DS
    Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population.
    Patten SB; Williams JV; Love EJ
    Can J Psychiatry; 1996 Sep; 41(7):469-76. PubMed ID: 8884037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
    Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and risk of epilepsy: a nested case-control study.
    Etminan M; Samii A; Brophy JM
    Neurology; 2010 Oct; 75(17):1496-500. PubMed ID: 20975051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.